Adaptate Biotherapeutics Raises $18 million in Series A2 Funding
Adaptate Biotherapeutics Raises $18 million in Series A2 Funding Investment [...]
Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer
Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer [...]
Adaptate Biotherapeutics establishes Scientific Advisory Board with Professor Adrian Hayday as Chair
Adaptate Biotherapeutics establishes Scientific Advisory Board with Professor Adrian [...]
Adaptate Biotherapeutics appoints Dr Mihriban Tuna as Chief Scientific Officer
Adaptate Biotherapeutics appoints Dr Mihriban Tuna as Chief Scientific [...]
Adaptate Biotherapeutics named as one of 20 European biotech companies to follow in 2020
Adaptate Biotherapeutics named as one of 20 European biotech companies [...]
Iontas & Adaptate Collaborate
IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for [...]
Adaptate Formed
Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate [...]